Categories: AlphaGraphs

Key highlights from Eli Lilly’s (LLY) Q1 2024 earnings results

Eli Lilly and Company (NYSE: LLY) reported first quarter 2024 earnings results today.

Worldwide revenue was $8.77 billion, up 26% from the year-ago quarter, driven by increases of 16% in volume and 10% due to higher realized prices.

Reported net income increased 67% to $2.24 billion, or $2.48 per share, compared to last year. Adjusted EPS rose 59% to $2.58.

For full-year 2024, revenue is expected to range between $42.4-43.6 billion. Reported EPS is expected to be $13.05-13.55 and adjusted EPS is estimated to be $13.50-14.00.

Prior performance

Recent Posts

Incyte Corporation Reports Strong 2025 Fiscal Results and Provides 2026 Guidance

Incyte achieved total revenue of $5.14 billion for the full year 2025, a 21% year-over-year…

2 minutes ago

CVS Health Reports Record 2025 Revenue of $402.1 Billion and Reaffirms 2026 Earnings Guidance

CVS Health Corporation (NYSE: CVS) reported record full-year 2025 consolidated revenues of $402.1 billion, a…

25 minutes ago

CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline

Healthcare solutions company CVS Health Corporation (NYSE: CVS) on Monday reported an increase in revenues…

41 minutes ago

DuPont Reports 2025 Full-Year Results and Issues 2026 Guidance Following Strategic Spinoffs

The industrial materials manufacturer reported flat fourth-quarter sales and a full-year organic growth rate of…

48 minutes ago

Harley-Davidson Q4 2025 Results Reflect Margin Pressure

Overview Harley-Davidson, Inc. reported consolidated fourth-quarter 2025 results that point to continued pressure on profitability…

59 minutes ago

KO Earnings: Key quarterly highlights from Coca-Cola’s Q4 2025 financial results

The Coca-Cola Company (NYSE: KO) reported its fourth quarter 2025 earnings results today. Net revenues…

1 hour ago